Cargando…

Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study

PURPOSE: Second primary malignancy (SPM) is challenging for treatment and long-term survival. We sought to investigate the standardized incidence rate (SIR), risk factors, and survival outcomes for SPM after renal cell carcinoma (RCC) treatment. METHOD: A nested case-control study was designed, we i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhixian, Yin, Yisheng, Wang, Jing, Zhu, Yunpeng, Li, Xing, Zeng, Xiaoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362854/ https://www.ncbi.nlm.nih.gov/pubmed/34395291 http://dx.doi.org/10.3389/fonc.2021.716741

Ejemplares similares

Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study
por: Wang, Zhixian, et al.
Publicado: (2021)

Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors
por: Xiao, Han, et al.
Publicado: (2022)

Multiple Patterns of Perirenal Fat Invasion Are Associated With a Poorer Prognosis Compared With Isolated Invasion: A Proposal for a Revision of T3aN0M0 TNM Staging System
por: Wang, Zhixian, et al.
Publicado: (2020)

Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies
por: Jing, Yaoyao, et al.
Publicado: (2023)

Incidence of second primary malignancies in women with different stages of breast cancer
por: Lin, Cheng-Yao, et al.
Publicado: (2023)

Second Primary Renal Cell Carcinoma With Nonrenal Malignancies: An Analysis of 118 Cases and a Review of Literature
por: Chen, Jinchao, et al.
Publicado: (2021)

Incidence and associated factors of developing second pelvic malignant neoplasms among prostate cancer patients treated with radiotherapy
por: Wang, Youbiao, et al.
Publicado: (2023)

Second Malignant Neoplasms in Patients With Rhabdomyosarcoma
por: Zhen, Hongnan, et al.
Publicado: (2021)

Risk Prediction of Second Primary Malignancies in Primary Early-Stage Ovarian Cancer Survivors: A SEER-Based National Population-Based Cohort Study
por: Xu, Jiaqin, et al.
Publicado: (2022)

Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
por: Marcheselli, Raffaella, et al.
Publicado: (2015)

Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
por: Mangone, Lucia, et al.
Publicado: (2023)

Association between malignancies and Marfan syndrome: a population-based, nested case–control study in Taiwan
por: Hsu, Chin-Wang, et al.
Publicado: (2017)

A Multilayer Nanofibrous Mat for the Topical Chemotherapy of the Positive Margin in Bladder Cancer
por: Wang, Jing, et al.
Publicado: (2022)

Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer
por: Li, Dan, et al.
Publicado: (2020)

Incidence features of second primary malignancy among gastric cancer survivors, 1992–2012
por: Li, Shuai, et al.
Publicado: (2020)

Association of plasma iron with the risk of incident cancer in Chinese adults with hypertension: a nested case-control study
por: Zhu, Hehao, et al.
Publicado: (2023)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020)

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer
por: Wu, Meijuan, et al.
Publicado: (2021)

Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
por: Ren, Xiang, et al.
Publicado: (2023)

The Impact of Malignancy on Assisted Reproductive Outcomes for Cancer Survivors: A Retrospective Case–Control Study
por: Li, Yuehong, et al.
Publicado: (2022)

Incidence, mortality, and survival analyses of patients with thymic lymphoma
por: Wang, Li, et al.
Publicado: (2022)

A malignant looking “renal” mass is not always renal cancer
por: Anyiam, Oluwaseun, et al.
Publicado: (2018)

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy
por: Zhang, Bo, et al.
Publicado: (2020)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Clinical and genetic characteristics in lymphoma patients with a second solid malignancy
por: Zhou, Di, et al.
Publicado: (2023)

Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
por: Jahreiß, Marie-Christina, et al.
Publicado: (2021)

Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis
por: Huang, Haowei, et al.
Publicado: (2023)

Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study
por: Ren, Xiang, et al.
Publicado: (2022)

Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors
por: Damuzzo, Vera, et al.
Publicado: (2019)

Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
por: Yin, Yisheng, et al.
Publicado: (2022)

Malignant Transformation in Vestibular Schwannoma: Clinical Study With Survival Analysis
por: Li, Jiuhong, et al.
Publicado: (2021)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a
por: Liu, Hailang, et al.
Publicado: (2021)

Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis
por: Kong, Junjie, et al.
Publicado: (2021)

Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study
por: Song, Congkuan, et al.
Publicado: (2020)

Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma
por: Zhang, Shi-Long, et al.
Publicado: (2020)

Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
por: Rice, Meghan A., et al.
Publicado: (2019)

Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma
por: Wang, Zhixian, et al.
Publicado: (2018)

Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma
por: Guo, Gang, et al.
Publicado: (2021)

Second primary malignancy risk after radiotherapy in rectal cancer survivors
por: Wang, Ti-Hao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h372pcsfrkpp6kngb45l69mufm